Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Catalent Inc (CTLT)

Catalent Inc (CTLT)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 19,240,018
  • Shares Outstanding, K 164,698
  • Annual Sales, $ 3,094 M
  • Annual Income, $ 173,000 K
  • 60-Month Beta 1.50
  • Price/Sales 6.30
  • Price/Cash Flow 31.56
  • Price/Book 6.42
Trade CTLT with:

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 12 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/20
See More
  • Average Estimate 0.50
  • Number of Estimates 5
  • High Estimate 0.54
  • Low Estimate 0.46
  • Prior Year 0.39
  • Growth Rate Est. (year over year) +28.21%

Price Performance

See More
Period Period Low Period High Performance
1-Month
101.18 +15.46%
on 12/29/20
120.18 -2.80%
on 01/20/21
+11.93 (+11.37%)
since 12/22/20
3-Month
86.43 +35.16%
on 10/30/20
120.48 -3.04%
on 11/09/20
+23.42 (+25.07%)
since 10/22/20
52-Week
31.04 +276.35%
on 03/18/20
120.48 -3.04%
on 11/09/20
+55.07 (+89.18%)
since 01/22/20

Most Recent Stories

More News
Pharmaceutical Contract Research and Manufacturing Market Research 2020-2024 | COVID-19 Industry Planning Structure | Technavio

--Boehringer Ingelheim International GmbH, Catalent Inc., and Icon Plc. will emerge as major pharmaceutical contract research and manufacturing market participants during 2020-2024

CTLT : 116.82 (-1.23%)
Ayala Pharmaceuticals (AYLA) Soars: Stock Adds 13.2% in Session

Ayala Pharmaceuticals (AYLA) saw a big move last session, as its shares jumped more than 13% on the day, amid huge volumes.

CTLT : 116.82 (-1.23%)
AYLA : 13.15 (+0.38%)
Catalent, Inc. Announces Second Quarter Fiscal Year 2021 Earnings Conference Webcast

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, gene and cell therapies, and consumer health products,...

CTLT : 116.82 (-1.23%)
Why Catalent (CTLT) is Poised to Beat Earnings Estimates Again

Catalent (CTLT) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

CTLT : 116.82 (-1.23%)
European Pharmaceutical Contract Development and Manufacturing Organization Market Outlook to 2030, Featuring Aenova Group, Baxter BioPharma Solutions, Catalent Inc, Pfizer CentreSource and More.

The "Europe Pharmaceutical Contract Development and Manufacturing Organization (CDMO) Market 2020-2030 by Category, Service Type (CMO, CRO), Therapeutic Application, End User, and Country" report has been...

CTLT : 116.82 (-1.23%)
Acorda (ACOR) Soars on Sale of Manufacturing Unit for Inbrija

Acorda (ACOR) inks an agreement to sell its Inbrija manufacturing operations in Chelsea for $80 million to Catalent. The company also announces a corporate restructuring plan to save costs. Shares up.

ACOR : 7.60 (+5.26%)
HALO : 49.50 (+4.21%)
CTLT : 116.82 (-1.23%)
BPMC : 101.36 (+1.50%)
Watch for Catalent Inc to Potentially Pullback After Gaining 2.63% Yesterday

Catalent Inc (NYSE:CTLT) traded in a range yesterday that spanned from a low of $109.36 to a high of $112.77. Yesterday, the shares gained 2.6%, which took the trading range above the 3-day high of $108.80...

CTLT : 116.82 (-1.23%)
Moderna (MRNA) COVID-19 Vaccine Gets Authorization in Europe

Moderna (MRNA) gets conditional use authorization for coronavirus vaccine, mRNA-1273, for use in adults in EU member states.

PFE : 36.55 (+0.19%)
MRNA : 131.02 (-1.47%)
CTLT : 116.82 (-1.23%)
BNTX : 108.44 (+2.85%)
Catalent, Inc. to Present at the 39th Annual J.P. Morgan Healthcare Conference

Catalent, Inc. (NYSE: CTLT), the leading global provider of advanced delivery technologies, development, and manufacturing solutions for drugs, biologics, cell and gene therapies, and consumer health products,...

JPM : 133.79 (-0.77%)
CTLT : 116.82 (-1.23%)
Looking for a Growth Stock? 3 Reasons Why Catalent (CTLT) is a Solid Choice

Catalent (CTLT) is well positioned to outperform the market, as it exhibits above-average growth in financials.

CTLT : 116.82 (-1.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Catalent, Inc. provides advanced delivery technologies and development solutions for drugs, biologics and consumer health products. It operates through Oral Technologies, Medication Delivery Solutions, and Development & Clinical Services. The Oral Technologies segment address the full diversity of the...

See More

Key Turning Points

3rd Resistance Point 120.62
2nd Resistance Point 119.57
1st Resistance Point 118.19
Last Price 116.82
1st Support Level 115.76
2nd Support Level 114.71
3rd Support Level 113.33

See More

52-Week High 120.48
Last Price 116.82
Fibonacci 61.8% 86.31
Fibonacci 50% 75.76
Fibonacci 38.2% 65.21
52-Week Low 31.04

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar